A recent study evaluating 500 serum specimens reported the development of a novel serum protein panel of three prostate cancer biomarkers, Filamin A, Filamin B, and Keratin-19 (FLNA, FLNB, and KRT19) using multivariate models for disease screening and prognosis [56]. This evidence concerns the gene KRT19 and prostate cancer.